Neuroplasticity and depression: Rewiring the brain's networks through pharmacological therapy (Review)
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
In modern society, depression is one of the most common mental illness; however, its pathophysiology is not yet fully understood. A great body of evidence suggests that depression causes changes in neuroplasticity in specific regions of the brain which are correlated to symptom severity, negative emotional rumination as well as fear learning. Depression is correlated with atrophy of neurons in the cortical and limbic brain regions that control mood and emotion. Antidepressant therapy can exhibit effects on neuroplasticity and reverse the neuroanatomical changes found in depressed patients. The investigation of fast-acting agents that reverse behavioral and neuronal deficiencies of chronic depression, especially the glutamate receptor antagonist NMDA ketamine, and the cellular mechanisms underlying the rapid antidepressant actions of ketamine and related agents are of real interest in current research. Actual medication such as serotonin (5-HT) selective reuptake inhibitor (SSRI) antidepressants, require weeks to months of administration before a clear therapeutic response. The current review aimed to underline the negative effects of depression on neuroplasticity and present the current findings on the effects of antidepressant medication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurogenesis in the adult human hippocampus
Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A.-M., Nordborg, C., Peterson, D. A., & Gage, F. H. (1998) · Nature Medicine · doi:10.1038/3305 · Cited by 6,369
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321 · cited 3×
“Treatment with escitalopram was proved to increase the serum level of brain‑derived neuro‑ trophic factor (BDNF) (78), therefore promoting neurogenesis in the hippocampus (79).”
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881 · cited 1×
“It was confirmed that chronic ketamine intake upregulates dopamine synthesis and levels (88).”
Mayberg, H. S., Liotti, M., Brannan, S. K., McGinnis, S., Mahurin, R. K., Jerabek, P. A., Silva, J. A., Tekell, J. L., Martin, C. C., Lancaster, J. L., et al. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.675 · Cited by 2,416 · cited 1×
“On account of the inhibitory effect of the prefrontal cortex on the amygdala (38), these changes are associated with impaired fear extinction and deregulation of acquired fear (39,40).”
Dopamine in motivational control: rewarding, aversive, and alerting
Bromberg-Martin, E. S., Matsumoto, M., & Hikosaka, O. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.022 · Cited by 2,396 · cited 1×
“A two‑dimensional model of neurotransmitter functions in depression describes this disorder as a combination of increasing negative affect and decreasing positive affect (62), which correlates with sadness and mood swings.”
The mesolimbic dopamine reward circuit in depression
Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059 · cited 1×
“Treatment with escitalopram was proved to increase the serum level of brain‑derived neuro‑ trophic factor (BDNF) (78), therefore promoting neurogenesis in the hippocampus (79).”
Glucocorticoids and Hippocampal Atrophy in Neuropsychiatric Disorders
Sapolsky, R. M. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.10.925 · Cited by 2,016
Stress Effects on Neuronal Structure: Hippocampus, Amygdala, and Prefrontal Cortex
McEwen, B. S., Nasca, C., & Gray, J. D. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.171 · Cited by 1,574
A functional anatomical study of unipolar depression
Drevets, W., Videen, T., Price, J., Preskorn, S., Carmichael, S., & Raichle, M. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-09-03628.1992 · Cited by 1,266
The Biochemistry of Affective Disorders
Coppen, A. (1967) · British Journal of Psychiatry · doi:10.1192/bjp.113.504.1237 · Cited by 1,230 · cited 1×
“In the case of major depressive disorder, but also milder cases of depression, a low level of norepinephrine has been observed, associated with difficulties in mobilizing for activity, attention or energy (65).”
Lower Hippocampal Volume in Patients Suffering From Depression: A Meta-Analysis
Campbell, S., Marriott, M., Nahmias, C., & MacQueen, G. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.4.598 · Cited by 1,156
Depressive rumination, the default-mode network, and the dark matter of clinical neuroscience
Hamilton, J. P., Farmer, M., Fogelman, P., & Gotlib, I. H. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.02.020 · Cited by 952 · cited 1×
“The DMN is an interconnection of different brain circuits that is activated during restful states, self‑referral thinking and also when foreseeing emotional response to certain situations, and planning future activities by taking into consideration other person's beliefs and intentions (43,44).”
Radley, J. J., Sisti, H. M., Hao, J., Rocher, A. B., McCall, T., Hof, P. R., McEwen, B. S., & Morrison, J. H. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.01.006 · Cited by 769 · cited 1×
“A study observed that excessive glucocorticoids can impair glial cell functions by inhibiting glucose transport in astrocytes, thus limiting their capacity to aid neurons and to clear the synapses of possibly damaging glutamate accumulation (34).”
Bora, E., Fornito, A., Pantelis, C., & Yücel, M. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.03.049 · Cited by 763
Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression.
Newport, D. J., Carpenter, L. L., McDonald, W. M., Potash, J. B., Tohen, M., Nemeroff, C. B., & The APA Council of Research Task Force on Novel Biomarkers and Treatments (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15040465 · Cited by 598
Wellman, C. L. (2001) · Journal of Neurobiology · doi:10.1002/neu.1079 · Cited by 594 · cited 1×
“Similar to the hippocampal effect, elevated levels of gluco‑ corticoids have been linked to decreased apical dendrites in the medial prefrontal cortex (35,36).”
Forbes, E. E., Hariri, A. R., Martin, S. L., Silk, J. S., Moyles, D. L., Fisher, P. M., Brown, S. M., Ryan, N. D., Birmaher, B., Axelson, D. A., et al. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07081336 · Cited by 582 · cited 1×
“Decreased levels of grey matter throughout this system may explain the core symptoms of depression (17,18).”
Izquierdo, A., Wellman, C. L., & Holmes, A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0474-06.2006 · Cited by 459 · cited 1×
“On account of the inhibitory effect of the prefrontal cortex on the amygdala (38), these changes are associated with impaired fear extinction and deregulation of acquired fear (39,40).”
The importance of norepinephrine in depression
Briley, M., & Chantal, M. (2011) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s19619 · Cited by 373 · cited 1×
“The uncertain hypothalamic pathway influences visceral and sensorimotor activity (64).”
Magariños, A. M., Deslandes, A., & McEwen, B. S. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00163-6 · Cited by 330 · cited 1×
“The end results are structural changes in specific regions in the brain (75,76).”
Enlargement of the Amygdala in Patients with a First Episode of Major Depression
Frodl, T., Meisenzahl, E., Zetzsche, T., Bottlender, R., Born, C., Groll, C., Jäger, M., Leinsinger, G., Hahn, K., & Möller, H.-J. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01359-2 · Cited by 316 · cited 1×
“Accompanying the increased thickness of the parietal cortex, an increase in the volume of the amygdala has been noted (22,23), along with a hyperactivity in this region (24,25).”
Acute Stress-induced Changes in Hippocampal/Prefrontal Circuits in Rats: Effects of Antidepressants
Rocher, C. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhg122 · Cited by 307 · cited 1×
“Treatment with fluoxetine showed similar results in blocking the effects of stress in the prefrontal cortex (84).”
Prolonged behavioral stress enhances synaptic connectivity in the basolateral amygdala
Vyas, A., Jadhav, S., & Chattarji, S. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.08.003 · Cited by 299
Delaveau, P., Jabourian, M., Lemogne, C., Guionnet, S., Bergouignan, L., & Fossati, P. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.09.032 · Cited by 281 · cited 1×
“A recent meta‑analysis suggests that depressive pathologies differ in terms of HPA axis reactivity, where depressed patients with melancholic features tend to have axis hyperactivation and those with atypical depression tend to have low axis activity (70).”
Cortisol and major depressive disorder-translating findings from humans to animal models and Back
Nandam, L. S., Brazel, M., Zhou, M., & Jhaveri, D. J. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00974 · Cited by 265 · cited 1×
“An increased proportion of depressed patients has been observed in cases of Cushing's disease or during treatment with high doses of synthetic corticosteroids (68).”
Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism
Gigliucci, V., O’Dowd, G., Casey, S., Egan, D., Gibney, S., & Harkin, A. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3024-x · Cited by 177
Geerlings, M. I., & Gerritsen, L. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.12.032 · Cited by 138
The learning of fear extinction
Furini, C., Myskiw, J., & Izquierdo, I. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.10.016 · Cited by 124
Cortical thickness predicts the first onset of major depression in adolescence
Foland‐Ross, L. C., Sacchet, M. D., Prasad, G., Gilbert, B., Thompson, P. M., & Gotlib, I. H. (2015) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2015.07.007 · Cited by 109
Jacobs, R. H., Barba, A., Gowins, J. R., Klumpp, H., Jenkins, L. M., Mickey, B. J., Ajilore, O., Peciña, M., Sikora, M., Ryan, K. A., et al. (2016) · Psychological Medicine · doi:10.1017/s0033291715002615 · Cited by 108
Neuroplasticity and the next wave of antidepressant strategies
Hayley, S., & Litteljohn, D. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00218 · Cited by 92 · cited 1×
“A single subanesthetic dose was observed to have a 52.6% response rate and lasts up to 3 days (85).”
InfluentialChen, Z., Peng, W., Sun, H., Kuang, W., Li, W., Jia, Z., & Gong, Q. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.209 · Cited by 70
Cited by
Almulla, A. F., Thipakorn, Y., Vasupanrajit, A., Tunvirachaisakul, C., Oxenkrug, G., Al-Hakeim, H. K., & Maes, M. (2022) · Cells · doi:10.3390/cells11193112 · Cited by 31
“Moreover, serotonin enhances proper neuroplasticity and maintains healthy neurons [113,114].”
BackgroundPsilocybin, an Effective Treatment for Major Depressive Disorder in Adults - A Systematic Review
Watford, T., & Masood, N. (2024) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.23.1120 · Cited by 23
Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery
Tanaka, M. (2026) · Biomedicines · doi:10.3390/biomedicines14061265
Metadata
- Authors
- Rădulescu, I., Drăgoi, A., Trifu, S., & Cristea, M.
- Venue
- Experimental and Therapeutic Medicine
- Publisher
- Spandidos Publications
- Published
- 2021-08-05
- Volume
- 22
- Issue
- 4
- Pages
- 1131-1131
- ISSN
- 1792-0981 (ISSN-L)
- 1792-1015
- OpenAlex
- W3187753905
- Cited by
- 121
- References
- 33
- FWCI
- 7.10
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.